Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Pemetrexed in Malignant Pleural Mesothelioma
NCT01085630Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Apr 2010
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in malignant pleural mesothelioma (MPM), sponsored by Cancer and Leukemia Group B. Started Apr 2010; status: completed.
02
Drugs
pemetrexed
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT01085630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01085630.